Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic psychiatric condition characterized by excessive, uncontrollable worry about various events or activities, occurring more days than not for at least six months. It significantly impairs daily functioning and social interactions.

Etiology is multifactorial, involving a complex interplay of genetic predisposition, neurobiological imbalances, and environmental stressors. Genetic heritability is estimated at 30-40%. Chronic stress, childhood trauma, and behavioral conditioning contribute to the development of the disorder.

GAD involves dysregulation of the amygdala, prefrontal cortex, and anterior cingulate cortex. Neurotransmitter imbalances—specifically involving gamma-aminobutyric acid (GABA), serotonin, and norepinephrine—disrupt the hypothalamic-pituitary-adrenal (HPA) axis, resulting in a persistent state of hyperarousal.

GAD has a lifetime prevalence of approximately 5-9% in the general population. It is twice as common in women as in men, with onset typically occurring in young adulthood, though it can manifest at any age.

• Family history of anxiety disorders
• Childhood trauma or abuse
• Chronic physical illness
• Substance use disorders
• Shy temperament in childhood
• High neuroticism

A. Early Symptoms

• Mild restlessness


• Difficulty concentrating


• Increased irritability


• Minor sleep disturbances B. Common Symptoms


• Excessive, uncontrollable worry


• Muscle tension


• Fatigue


• Persistent "on edge" feeling C. Advanced Symptoms


• Psychosomatic symptoms (e.g., GI distress)


• Social withdrawal


• Severe insomnia


• Panic-like autonomic arousal D. Emergency Symptoms


• Suicidal ideation


• Self-harm behaviors


• Severe panic attacks with chest pain

• Elevated resting heart rate (tachycardia)
• Elevated blood pressure
• Hyperreflexia
• Muscle tension (neck and shoulders)
• Fine tremor

A. Clinical Assessment: DSM-5-TR criteria application.
B. Laboratory Testing: Rule out endocrine/metabolic causes.
C. Imaging Studies: Generally not required; used to rule out organic pathology.
D. Functional Tests: Psychological screening inventories (GAD-7).
E. Biopsy Findings: N/A.
F. Genetic Testing: Not currently clinical standard.
G. Differential Diagnosis: Hyperthyroidism, cardiac arrhythmia, substance-induced anxiety.

Complete Blood Count (CBC)
Type: Blood Test
Purpose: Identify anemia or infection.
Expected Findings: Normal range.
Interpretation: Rules out secondary causes of fatigue. Thyroid Stimulating Hormone (TSH)
Type: Blood Test
Purpose: Screen for hyperthyroidism.
Expected Findings: Normal range.
Interpretation: Elevated TSH rules out thyroid-induced anxiety.

MRI of the Brain: Used only when neurological symptoms are present to rule out lesions or tumors. Findings are typically unremarkable in primary GAD.

• Panic Disorder: Characterized by discrete, sudden attacks.
• Hyperthyroidism: Autonomic symptoms mimicking anxiety.
• Major Depressive Disorder: Often comorbid but distinct in primary focus.
• Substance Use: Withdrawal symptoms can mimic GAD.

• Clinical depression
• Substance use disorders
• Chronic pain conditions
• Cardiovascular disease (prolonged sympathetic activation)

A. Lifestyle Modifications: Regular exercise, caffeine reduction, sleep hygiene.
B. Preventive Measures: Stress management training.
C. Medical Treatment: - SSRIs: Escitalopram, Sertraline.

• SNRIs: Venlafaxine, Duloxetine.


• Anxiolytics: Buspirone.

Chronic but manageable. Most patients respond well to combined CBT and pharmacotherapy. Relapse is common if medication is discontinued prematurely.

Early intervention in children with "shy" temperaments and maintenance of psychological health during high-stress life events.

The following homeopathic remedies have been historically indicated for symptoms associated with Generalized Anxiety Disorder. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Panic Attack & Somatic Anxiety Estimator

Evaluates somatic anxiety and panic severity using physiological symptoms (palpitations, sweating, dyspnea, tremors) and cognitive distress indicators.